维普期刊资源整合服务平台（V6.5）

453篇 您的检索式：作者名="Barst"

选中清除导出查看参考文献查看引证文献引用追踪共23页首页上一页第1页下一页末页 /23 跳转

	题名	作者	年代	出处	被引量
1	使用选择性内皮素A受体拮抗剂sitaxsentan治疗肺动脉高压显示文摘	Barst RJ Langleben D Badesch D 菅鑫妍	2006	中国处方药2006，5，8：	38
2	ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension显示文摘	Vallerie V. McLaughlin Stephen L. Archer David B. Badesch Robyn J. Barst Harrison W. Farber Jonathan R. Lindner Michael A. Mathier Michael D. McGoon Myung H. Park Robert S. Rosenson Lewis J. Rubin Victor F. Tapson John Varga	2009	Journal of the American College of Cardiology2009，，17：	2
3	Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)显示文摘	Raymond L. Benza Dave P. Miller Mardi Gomberg-Maitland Robert P. Frantz Aimee J. Foreman Christopher S. Coffey Adaani Frost Robyn J. Barst David B. Badesch C. Gregory Elliott Theodore G. Liou Michael D. McGoon	2010	Circulation2010，，2：	2
4	A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension显示文摘	Barst RJ Rubin LJ Long WA		0，，：	2
5	Vasodilator therapy for primarypulmonary hypertension in children显示文摘	Barst RJ Maislin G Fishman AP	1999	Circulation1999，99，9：	1
6	Diagnosis and differential assessment of pulmonary arterial hypertension显示文摘	Barst R McGoon Mj Torbicki Aj	2004	J Am Coll Cardiol2004，43，12：	1
7	Long-term prostacyclin forpulmonary hypertension ith associated congenital heart defects显示文摘	Rosenzweig EB Kerstein D Barst RJ	1999	Circulation1999，99，14：	1
8	A comparison of continuous epoprostenal(prostacyclin) with conventional therapy for primary pulmonary hypertension显示文摘	Rubin LJ Long WA	1996	New Engl Med1996，334，：	1
9	Mapping of Familial primary pulmonary hypertension locus(PPH1) to chromosome 2q31-q32显示文摘	Morse JH Jones AC Barst RJ	1997	Circulation1997，95，12：	1
10	Mapping of familial primary pulmonary hypertension locus(PPH1) to chromo some 2q31-q32显示文摘	Jones AC Barst RJ	1997	Circulation1997，95，12：	1
11	Is it possible to reverse the endothelial dysfunction in pulmonary arterial hypertension?显示文摘	BARST R	2007	J Am Coll Cardial2007，49，14：	1
12	Diagnosis and differential assessment of pulmonary arterial hypertension显示文摘	BARST R J MCGOON M TBRBICKI A	2004	J Am Coll Cardiol2004，43，12：	1
13	Continuous subcutaneous in fusion o f treprostinil,a prostacyclin analogue,in patients with pulmonary artrial hypertension显示文摘	Simonneau G Barst ER Galie N	2002	Am J Respir Crit Care Med2002，16，6：	1
14	Guidelines on diagnosis and treatment of pulmonary arterial hypertension显示文摘	Galie N Torbicki A Barst R	2005	Rev Esp Cardiol2005，58，5：	1
15	Pulmonary arterial hypertension in children 显示文摘	Widlitz A Barst RJ	2003	Eur Respir J2003，21，1：	1
16	Bosentan therapy for pulmonary arterial hypertension显示文摘	Rubin L J Badesch D B Barst R J	2002	N Engl J Med2002，346，2：	1
17	Recent advances in the treatment of pediatric pulmonary artery hypertension显示文摘	BARST R J	1999	Pediatr Clin North Am1999，46，2：	1
18	Guidelines on diagnosis and treatment of pulmonary arterial hypertension 显示文摘	Galie N Torbicki A Barst R	2004	Eur Heart J2004，25，24：	1
19	Beraprost therapy for pulmonary arterial hypertension显示文摘	Barst RJ McGoon M McLaughlin V	2003	J Am Coll Cardiol2003，41，12：	1
20	Future Perspectives for the Treatment of Pulmonary Arterial Hypertension显示文摘	Hossein A. Ghofrani Robyn J. Barst Raymond L. Benza Hunter C. Champion Karen A. Fagan Friedrich Grimminger Marc Humbert Gérald Simonneau Duncan J. Stewart Carlo Ventura Lewis J. Rubin	2009	Journal of the American College of Cardiology2009，，1：	1

返回顶部每页显示：

共23页首页上一页第1页下一页末页 /23 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示